Novozymes A/S Reports Non-GAAP EPS of €0.78 and Revenue of €2.09 Billion
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 21 2025
0mins
Source: SeekingAlpha
Financial Performance: Novozymes A/S reported a Non-GAAP EPS of €0.78 for the first half of the year.
Revenue Growth: The company achieved a revenue of €2.09 billion, reflecting a 14.2% increase year-over-year.
Industry Position: Novozymes is recognized as an industry leader with defensive characteristics and solid growth potential.
Additional Resources: The press release includes links to Seeking Alpha’s Quant Rating, historical earnings data, and a dividend scorecard for further financial insights.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
